One-Year Prophylactic Treatment of Euthyroid Hashimoto's Thyroiditis Patients with Levothyroxine: Is There a Benefit?
Studies in animal models of spontaneous Hashimoto's autoimmune thyroiditis (HT) show that prophylactic treatment with levothyroxine (LT 4 ) can reduce incidence and degree of lymphocytic infiltration in HT. The aim of the present study was to clarify whether there is a benefit of prophylactic t...
Gespeichert in:
Veröffentlicht in: | Thyroid (New York, N.Y.) N.Y.), 2001-03, Vol.11 (3), p.249-255 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Studies in animal models of spontaneous Hashimoto's autoimmune thyroiditis (HT) show that prophylactic treatment with levothyroxine (LT
4
) can reduce incidence and degree of lymphocytic infiltration
in HT. The aim of the present study was to clarify whether there is a benefit of prophylactic treatment with LT
4
in patients with euthyroid HT with respect to the progression of the autoimmune
process. Twenty-one patients with euthyroid HT were checked for thyroid function (thyrotropin [TSH], free triiodothyronine [FT
3
], free thyroxine [FT
4
]), thyroid volume, antibodies
(thyroglobulin [Tg-Ab], thyroid peroxidase [TPO-Ab]), and lymphocyte subsets. Peripheral (PBL) and thyroid-derived lymphocytes (TL) were analyzed by triple color flow cytometry. One-half of the patients
with euthyroid HT were treated with LT
4
for 1 year (
n
= 10). The other half (
n
= 11) were never treated with LT
4
. TL were obtained by fine-needle aspiration biopsy (FNAB).
Thirteen healthy subjects (C) without medical history of thyroid disease served as controls concerning PBL, and patients with nontoxic nodular goiter (NG;
n
= 10) served as controls concerning TL.
Thyroid-derived T-helper cells were found more frequently in euthyroid patients with HT compared to patients with NG (
p
< 0.01). After 1 year of therapy with LT
4
, TPO-Abs and B lymphocytes
decreased significantly only in the treated group of euthyroid patients with HT (
p
< 0.05). In contrast, TPO-Abs levels did not change or even increased in untreated euthyroid patients with HT.
Thyroid volume did not differ before and after therapy. Prophylactic treatment of euthyroid patients with HT reduced both serological and cellular markers of autoimmune thyroiditis. Therefore, prophylactic
LT
4
treatment might be useful to stop the progression or even manifestation of the disease. However, the long-term clinical benefit of prophylactic LT
4
therapy in euthyroid patients
with HT is yet to be established. |
---|---|
ISSN: | 1050-7256 1557-9077 |
DOI: | 10.1089/105072501750159651 |